Human Immunodeficiency Virus Diagnostic Testing of Infants at Clinical Sites in North America 2002―2006READ, Jennifer S; BROGLY, Susan; BASAR, Michael et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 7, pp 614-618, issn 0891-3668, 5 p.Article

Towards more effective public health programming for injection drug users: Development and evaluation of the injection drug user quality of life scaleBROGLY, Susan; MERCIER, Celine; BRUNEAU, Julie et al.Substance use & misuse. 2003, Vol 38, Num 7, pp 965-992, issn 1082-6084, 28 p.Article

Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilizationBRUNEAU, Julie; BROGLY, Susan B; TYNDALL, Mark W et al.Addiction (Abingdon. Print). 2004, Vol 99, Num 6, pp 727-737, issn 0965-2140, 11 p.Article

HIV-positive notification and behavior changes in montreal injection drug usersBROGLY, Susan B; BRUNEAU, Julie; LAMOTHE, Francois et al.AIDS education and prevention. 2002, Vol 14, Num 1, pp 17-28, issn 0899-9546Article

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapyYLITALO, Nathalie; BROGLY, Susan; HUGHES, Michael D et al.Archives of pediatrics & adolescent medicine. 2006, Vol 160, Num 8, pp 778-787, issn 1072-4710, 10 p.Article

Malignancy in perinatally human immunodeficiency virus-infected children in the United StatesKEST, Helen; BROGLY, Susan; MCSHERRY, George et al.The Pediatric infectious disease journal. 2005, Vol 24, Num 3, pp 237-242, issn 0891-3668, 6 p.Article

Participation of HIV-infected pregnant women in research in the United StatesBROGLY, Susan; READ, Jennifer S; SHAPIRO, David et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 51-53, issn 0889-2229, 3 p.Article

Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretroviralsOUYANG, David W; BROGLY, Susan B; MING LU et al.AIDS (London). 2010, Vol 24, Num 1, pp 109-114, issn 0269-9370, 6 p.Article

Prenatal Protease Inhibitor Use and Risk of Preterm Birth among HIV-Infected Women Initiating Antiretroviral Drugs during PregnancyPATEL, Kunjal; SHAPIRO, David E; BROGLY, Susan B et al.The Journal of infectious diseases. 2010, Vol 201, Num 7, pp 1035-1044, issn 0022-1899, 10 p.Article

Short Communication: Transplacental Nucleoside Analogue Exposure and Mitochondrial Parameters in HIV-Uninfected ChildrenBROGLY, Susan B; DIMAURO, Salvatore; VAN DYKE, Russell B et al.AIDS research and human retroviruses. 2011, Vol 27, Num 7, pp 777-783, issn 0889-2229, 7 p.Article

Mode of Delivery and Infant Respiratory Morbidity Among Infants Born to Hlv-1-Infected WomenLIVINGSTON, Elizabeth G; YANLING HUO; PATEL, Kunjal et al.Obstetrics and gynecology (New York. 1953). 2010, Vol 116, Num 2, pp 335-343, issn 0029-7844, 9 p., 1Article

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected childrenBROGLY, Susan B; YLITALO, Nathalie; SEAGE, George R et al.AIDS (London). 2007, Vol 21, Num 8, pp 929-938, issn 0269-9370, 10 p.Article

Prevalence of Congenital Anomalies in Infants With In Utero Exposure to AntiretroviralsKNAPP, Katherine M; BROGLY, Susan B; MUENZ, Daniel G et al.The Pediatric infectious disease journal. 2012, Vol 31, Num 2, pp 164-170, issn 0891-3668, 7 p.Article

Possible Mitochondrial Dysfunction and Its Association with Antiretroviral Therapy Use in Children Perinatally Infected with HIVCRAIN, Marilyn J; CHERNOFF, Miriam C; VAN DYKE, Russell B et al.The Journal of infectious diseases. 2010, Vol 202, Num 2, pp 291-301, issn 0022-1899, 11 p.Article